Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8746L |
I-49 free base
Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-6-(tetrahydro-2H-pyran-4-yl)-,I-49 |
Raf | MAPK |
I-49 free base (Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-6-(tetrahydro-2H-pyran-4-yl)-) 是一种新型苄氨基取代的吡啶并嘧啶酮,可作为 SOS1 抑制剂。 | |||
TP1123 |
IGF-I (24-41) TFA (135861-49-3 free base)
Insulin-like Growth Factor I (24-41) (TFA),IGF-I (24-41) TFA |
||
IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).IGF-I (24-41) (TFA) is amino acids 24 to 41 fragment of Insulin-like Growth |